Specification of areas to which section 234AA applies (No. 22/15) – Gold Coast Airport
C2022G01062 • Published On: 27/10/2022

Specialist Medical Review Council Declaration: Review of a decision by the Repatriation Medical Authority not to determine Statements of Principles for “Chemically acquired brain injury caused by mefloquine, tafenoquine or primaquine”
C2018G00730 • Published On: 18/09/2018

Specialist Medical Review Council Declaration: Statements of Principles 53 and 54 of 2013 concerning fibrosing interstitial lung disease and Nos. 55 and 56 of 2013 concerning asbestosis
C2015G02056 • Published On: 11/12/2015

Specialist Medical Review Council Declaration: Statements of Principles Nos. 22 & 23 of 2010 concerning Alzheimer-type Dementia
C2013G01392 • Published On: 16/09/2013

Specialist Medical Review Council Declaration: Statements of Principles Nos. 50 and 51 of 2017 concerning rheumatoid arthritis
C2018G00818 • Published On: 18/10/2018

Specialist Medical Review Council Declaration: Statements of Principles Nos. 55 and 56 of 2014 concerning chronic multisymptom illness
C2018G00623 • Published On: 07/08/2018

Specialist Medical Review Council Declaration: Statements of Principles Nos. 69 and 70 of 2012 concerning Myeloma
C2014G00762 • Published On: 13/05/2014

Specialist Medical Review Council Declaration: Statements of Principles Nos. 89 and 90 of 2011 concerning Diabetes Mellitus
C2014G00763 • Published On: 13/05/2014

Specialist Medical Review Council Declaration: Statements of Principles Nos. 9 and 10 of 2005 concerning chronic lymphoid leukaemia
C2013G01753 • Published On: 26/11/2013

Specialist Medical Review Council - Notification of amended closing date for written submissions
C2014G01772 • Published On: 27/10/2014

Specialist Medical Review Council - Notification of amended closing date for written submissions - Lyme Disease
C2016G01255 • Published On: 19/09/2016

Specialist Medical Review Council - Notification of intention to carry out a review concerning “chemically acquired brain injury caused by mefloquine, tafenoquine or primaquine”
C2017G01186 • Published On: 06/11/2017

Specialist Medical Review Council - Notification of Intention to carry out a review for Hashimoto Thyroiditis
C2022G00921 • Published On: 27/09/2022

Specialist Medical Review Council - Notification of intention to carry out a review for motor neuron disease
C2017G01185 • Published On: 06/11/2017

Specialist Medical Review Council - Notification of intention to carry out a review for motor neuron disease
C2017G01108 • Published On: 09/10/2017

Specialist Medical Review Council - Notification of Intention to Carry Out a Review of Statements of Principles for Chronic Multisymptom Illness
C2014G01435 • Published On: 28/08/2014

Specialist Medical Review Council - Notification of Intention to Carry Out a Review of Statements of Principles for Lyme Disease
C2016G00802 • Published On: 10/06/2016

Specialist Medical Review Council - Notification of Intention to Carry Out a Review of Statements of Principles for non-Hodgkin's lymphoma
C2014G01563 • Published On: 17/09/2014

Specialist Medical Review Council: Notification of Review and Extension of submission date - fibrosing interstitial lung disease and asbestosis
C2014G00433 • Published On: 12/03/2014

Specialist Medical Review Council - Notification of termination of review - Lyme disease
C2017G00178 • Published On: 10/02/2017

Specification of areas to which section 234AA applies (No. 21/23) – Hobart International Airport
C2021G00744 • Published On: 27/09/2021

Specification of areas to which section 234AA applies (No. 21/26) – Sydney International Airport
C2021G00762 • Published On: 05/10/2021